Myriad Genetics CFO holds 287,193 shares

MYRIAD GENETICS’ CFO had 2,555 MYGN shares withheld for taxes on RSU vesting and now holds 287,193 shares directly.

Available on EDGAR 09/22/2026 - 04:12 PM EDT Accepted by SEC EDGAR 09/22/2026 - 04:12 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

MYRIAD GENETICS INC (MYGN) reported that its Chief Financial Officer, Benjamin Richard Wheeler, had 2,555 shares of common stock withheld on September 21, 2026 to satisfy tax withholding obligations linked to vesting restricted stock units. The shares were valued at $4.01 per share for this purpose. After this withholding, Wheeler directly holds 287,193 shares of MYGN common stock. No Rule 10b5-1 trading plan is reported for this transaction.

Insider Trade Summary

Tax Withholding: 2,555 shares

Tax Withholding 1 txn

Insider Wheeler Benjamin Richard

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock F1	2,555	$4.01	$10K

Holdings After Transaction: Common Stock — 287,193 shares (Direct)

Footnotes (1)

1. F1. Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on September 21, 2026.

Key Figures

Shares withheld for taxes: 2,555 shares Reference share price: $4.01 per share Shares held after transaction: 287,193 shares +1 more

4 metrics

Shares withheld for taxes 2,555 shares Common stock withheld September 21, 2026 to satisfy tax withholding on RSU vesting

Reference share price $4.01 per share Closing price of MYGN common stock on September 21, 2026 used to determine shares withheld

Shares held after transaction 287,193 shares Direct MYGN common stock holdings of CFO after the withholding transaction

Transactions for tax liability 1 transaction, 2,555 shares Code F transaction reported for payment of tax liability by withholding securities

Key Terms

restricted stock units, tax withholding obligations, closing price

3 terms

restricted stock units financial

"in connection with the vesting of restricted stock units previously granted"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligations financial

"withheld by the Issuer to satisfy tax withholding obligations in connection"

closing price financial

"determined based on the closing price of Issuer's Common Stock"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did MYGN’s CFO report on this Form 4?

The CFO of MYRIAD GENETICS INC, Benjamin Richard Wheeler, reported that 2,555 shares of MYGN common stock were withheld on September 21, 2026 to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units.

Was the MYGN CFO’s Form 4 transaction a market sale of shares?

No. The Form 4 states the 2,555 shares were withheld by the issuer to cover tax withholding obligations on vesting restricted stock units, not sold in the open market, and it is coded as payment of tax liability by delivering or withholding securities.

How many MYGN shares does the CFO hold after this reported transaction?

Following the tax-withholding transaction, Benjamin Richard Wheeler is reported to directly hold 287,193 shares of MYRIAD GENETICS INC common stock. This figure reflects his position after the issuer withheld 2,555 shares in connection with RSU vesting.

What price per share was used for the MYGN tax-withholding event?

The shares withheld to satisfy tax obligations were valued using a price of $4.01 per share. A footnote explains that the number of shares withheld was determined based on the closing price of MYGN’s common stock on September 21, 2026.

Was the MYGN CFO’s Form 4 transaction under a Rule 10b5-1 trading plan?

The filing indicates that no Rule 10b5-1 trading plan is reported for this transaction, and the document-level checkbox affirming a 10b5-1 plan is not checked.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wheeler Benjamin Richard

(Last) (First) (Middle)

322 NORTH 2200 WEST

(Street)

SALT LAKE CITY UTAH 84116

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MYRIAD GENETICS INC [ MYGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/21/2026		F		2,555(1)	D	$4.01	287,193	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on September 21, 2026.

Remarks:

	By: Justin Hunter For: Benjamin R. Wheeler	09/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)